The guidance says most insect bites and stings get better in a few hours or days and can be treated at home. It recommends symptomatic care, but it does not compare branded products or support a claim that Psilobalsam relieves symptoms faster than Dermodrin.

An open-label, controlled study was performed on 41 healthy participants who received Aedes aegypti mosquito bites on the forearm. The test product (a cream containing zinc oxide and other ingredients) was applied to one arm, with the other arm left untreated. The onset of pruritus relief in the treated group (25 ± 21.7 minutes) was significantly faster compared to the untreated group (118.7 ± 304.8 minutes), and the reduction in itching severity at 1 hour was also greater. The study did not involve Dermodrin (dimetindene-containing) or Psilobalsam, and no head‑to‑head comparison between such products is reported.

This clinical study evaluated a device applying concentrated heat for treatment of insect bites. It reports that itch was reduced by 57% for mosquito bites within the first minute after treatment and by 81% at 5–10 minutes after treatment. The paper compares the heat device with sham treatment and indirect comparators but does not evaluate topical drug products such as Dermodrin or Psilobalsam, nor does it provide data on their relative speed of symptom relief.

Crotamiton is described as "a scabicidal and antipruritic agent" used topically for scabies and **pruritus** (itching). It is included in various topical preparations for the relief of itching, but the entry does not present comparative clinical data versus other specific products or brands for insect bites.

Dibucaine is described as “a local anesthetic of the amide type that is used topically to relieve pain and itching caused by conditions such as sunburn, insect bites, or hemorrhoids.” It is the active ingredient in various topical preparations marketed for pruritus and insect bites relief. This establishes dibucaine as a standard topical antipruritic/local anesthetic comparator for products like Dermodrin in some markets.

Dimetindene is characterized as “an H1-receptor antagonist used in the treatment of allergies, pruritus and insect bites when administered orally or topically.” It is the active substance in several topical antihistamine gels and creams indicated for insect bites and itching, making it relevant as a reference class of products similar to those that might be compared with Psilobalsam or Dermodrin.

The review states that when mosquito bites occur, treatment is aimed at alleviating pruritus through topical applications and oral antihistamines. It describes the immediate wheal after a bite peaking in 20–30 minutes and the delayed pruritic papules peaking in 24–36 hours, but it does not compare Psilobalsam with Dermodrin.

DrugBank notes that crotamiton is indicated for "the treatment of scabies and pruritus" and is formulated as topical creams and lotions. It does not cite randomized controlled trials comparing **crotamiton-containing products** with other named preparations specifically for insect bites or relative speed of symptom relief.

The Summary of Product Characteristics for Psilobalm 1% cream states that its active substance is lidocaine 1% w/w. The therapeutic indications are listed as: “For the symptomatic relief of pruritus, minor skin irritations and insect bites.” Under pharmacodynamic properties it notes that lidocaine is a local anaesthetic of the amide type producing reversible blockade of nerve impulse conduction, leading to relief of itching and pain after topical application.

The UK SmPC for Eurax (crotamiton) 10% cream states it is indicated for "the treatment of scabies" and "for the relief of pruritus" including in certain skin conditions. Under pharmacodynamics it describes antipruritic properties, but the document does **not** contain clinical trial data comparing the onset of action or efficacy against other bug‑bite or anti‑itch products such as Dermodrin, nor against a product called Psilobalsam.

The StatPearls review on insect bites explains that treatment "focuses on controlling pruritus" and lists options such as topical corticosteroids, oral antihistamines, and other symptomatic measures. It does **not** mention Psilobalsam, and it does not provide head‑to‑head data comparing specific branded topical antipruritic agents like Dermodrin with any balsam‑containing preparation for speed of relief.

This review of topical therapies for pruritus discusses a wide range of agents including topical corticosteroids, calcineurin inhibitors, pramoxine, topical doxepin, capsaicin and others. It notes that “pramoxine, which is thought to exert antipruritic effects by stabilizing membranes of sensory nerves, effectively decreases itch in patients with xerosis, uremic pruritus, and psoriasis and has been used as a single agent or in combination with mild potency topical steroids.” It further states that, in a randomized, double‑blind, comparative trial, “twice daily application of pramoxine 1% lotion for 4 weeks significantly reduced pruritus compared to a control lotion.” No mention is made of Psilobalsam, Dermodrin, or any comparative trial between these two specific preparations.

This review reports that topical calcineurin inhibitors can reduce pruritus within 48 hours and that some topical treatments can provide rapid relief of itch. It is relevant for general onset-of-action context, but it does not provide evidence that Psilobalsam works faster than Dermodrin for insect bites.

This review of treatments for simple insect bites in the UK concludes that there is "little evidence" from randomized controlled trials to support many commonly used remedies. It discusses topical antihistamines, corticosteroids, and other symptomatic treatments, but it does **not** reference Psilobalsam or Dermodrin by name and does not present any study comparing these two products or their relative speed of itch relief.

A targeted search of the PubMed database using the terms “Psilobalsam”, “Dermodrin”, “pruritus”, and “trial” returns no randomized controlled trials or comparative clinical studies directly evaluating Psilobalsam versus Dermodrin for insect bites or itching. The absence of indexed clinical trials under these keywords suggests that, as of the latest update, no head‑to‑head efficacy or onset‑of‑relief data between these two branded products has been published in the peer‑reviewed medical literature.

The Cochrane review on interventions for insect bites and stings evaluates trials of antihistamines, corticosteroids and other agents for symptom relief. It finds limited and low‑quality evidence for many treatments. The included studies do not feature Psilobalsam, and there are no head‑to‑head comparisons of **Psilobalsam versus crotamiton‑ or diphenhydramine‑based creams** such as Dermodrin with respect to onset of itch relief.

This randomized, placebo‑controlled study evaluates oral desloratadine and montelukast for chronic idiopathic urticaria and reports on changes in pruritus and hive symptoms. The authors conclude that “desloratadine is highly effective for the treatment of patients affected by CIU” and that “no differences were found between the desloratadine group and the desloratadine plus montelukast group.” The paper does not discuss topical products such as Psilobalsam or Dermodrin, nor does it provide any comparative data between topical local anesthetic or antiseptic creams for insect bite relief.

Mayo Clinic guidance suggests that most mosquito bites stop itching and heal on their own in a few days, and that self-care may include applying calamine lotion, nonprescription antihistamine cream or corticosteroid cream, ice, pressure, or taking an oral antihistamine. The article does not cite evidence comparing different branded topical agents, and does not mention Psilobalsam or Dermodrin or report time‑to‑relief comparisons between specific products.

NHS guidance for insect bites and stings states that most bites and stings can be treated with simple measures such as cleaning the area, applying a cold pack, and using “creams for itching and pain, such as hydrocortisone cream, antihistamine cream or local anaesthetic cream.” The page does not mention Psilobalsam or Dermodrin by name and does not endorse one branded cream over another, nor does it cite evidence that any specific proprietary product offers faster relief.

The article states that treatment of insect bite reactions is symptomatic, with topical corticosteroids and antihistamines for mild reactions and short-course systemic corticosteroids for severe reactions. It does not present evidence comparing Psilobalsam and Dermodrin.

The Drugs.com international listing for Psilobalm identifies it as a topical preparation whose active ingredient is lidocaine (lignocaine). It states that Psilobalm is used for the symptomatic relief of pruritus and minor skin irritation such as sunburn or insect bites. The entry provides product composition and indications but does not include clinical trial data or any statement that Psilobalm provides faster symptom relief than Dermodrin or other topical preparations.

The article says that topical antipruritic agents, such as camphor and menthol, or topical anesthetics like pramoxine, can be used several times a day for rapid relief. It also notes that treatment is based on symptom control and does not mention a Psilobalsam-versus-Dermodrin comparison.

This review of over‑the‑counter itch‑relief products summarizes evidence for various gels and creams used for pruritus, including insect bites. It notes a study where an itch relief gel showed faster onset and greater itch reduction at 8 hours compared with a comparator, but the named products do not include Psilobalsam or Dermodrin, and the article offers no direct comparison between these two specific preparations.

Dimetindene is described as a first-generation selective H1 antihistamine that can be administered orally or topically for allergic conditions. Topical formulations are used for the relief of itching associated with insect bites and other minor skin irritations. The entry provides pharmacologic information on the active ingredient found in products such as Dermodrin but does not present clinical trial data comparing the speed of symptom relief to other proprietary mixtures like Psilobalsam.

Reporting on a review in the UK journal Drug and Therapeutics Bulletin, CBS News notes that the review found 'little evidence' that common bug bite remedies, including antihistamine pills and steroid creams, are effective for relieving itching from bites. The article also states that creams containing painkillers or anesthetics were only 'marginally effective' and sometimes worsened allergic reactions. The piece does not discuss Psilobalsam or Dermodrin and reinforces that high‑quality comparative data between specific over‑the‑counter preparations for bug bites are limited.

This PubMed‑indexed German clinical study compares a **crotamiton** preparation with pheniramine maleate in patients with pruritus of various origins. The abstract reports improvements in itching with both treatments, but it does not involve insect bites as a defined indication and does not include any product named Dermodrin or Psilobalsam. No statements are made about Psilobalsam providing faster relief than crotamiton‑containing products.

The SmPC for Dermadrin 2% cream (a topical **diphenhydramine** product available in some markets under similar names to Dermodrin) states it is indicated for "the symptomatic relief of pain and itching associated with minor skin irritations, insect bites and stings". The document describes its antihistaminic and local anaesthetic actions but does not provide comparative clinical data versus Psilobalsam or any balsam‑containing product, nor does it describe time‑to‑onset comparisons.

The page recommends cold compresses and topical medicated preparations, including a topical anesthetic or hydrocortisone cream, to reduce itch and discomfort. It provides general treatment advice only and does not mention Psilobalsam or Dermodrin.

Dermodrin is commonly marketed as a topical antipruritic/anesthetic cream for itch relief, while Psilobalsam is also marketed for itch and minor skin irritation. I am not aware of high-quality head-to-head clinical evidence showing that Psilobalsam provides faster symptom relief than Dermodrin for insect bites.

A German online pharmacy listing describes Psilo Balsam as a topical product for itching from insect bites and sunburn and notes that it contains ingredients such as diphenhydramine and cooling excipients (according to the listing). The page consists of consumer information and marketing text and does not cite randomized controlled trials, time‑to‑relief data, or comparisons with other products like Dermodrin.